Dr. Aragon-Ching is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8081 Innovation Park Dr
Level 5 - Great Falls Clinic
Fairfax, VA 22031Phone+1 571-472-1180Fax+1 571-472-1197- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2004 - 2008
Albert Einstein Healthcare NetworkChief Residency, Internal Medicine, 2003 - 2004- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2000 - 2003
University of Santo TomasClass of 1997
University of Santo TomasBS, Physical Therapy, Cum Laude, 1988 - 1993
Certifications & Licensure
VA State Medical License 2015 - 2024
DC State Medical License 2008 - 2018
MD State Medical License 2004 - 2018
PA State Medical License 2001 - 2004- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Named Top Doctor Northern Virginia Magazine, 2017, 2019-2021
- Named Top Doctor Washingtonian, 2018
- Named Top Doctor International Association of Oncologists, 2018
- Join now to see all
Clinical Trials
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
- A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors Start of enrollment: 2015 Jan 01
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
- Join now to see all
Publications & Presentations
PubMed
- Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients.David J Einstein, Jeanny B Aragon-Ching, Fatima Karzai, Ravi A Madan> ;Current Opinion in Oncology. 2024 May 1
- Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.Shore, N., Gratzke, C., Feyerabend, S., Werbrouck, P., Carles, J., Vjaters, E., Tammela, T., Morris, D., Aragon-Ching, J., Concepcion, R., Emmenegger, U., Fleshner, N....> ;The Oncologist. 2024 Feb 23
- 1 citationsAvelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Mainten...Srikala S Sridhar, Thomas Powles, Miguel Á Climent Durán, Se Hoon Park, Francesco Massari, Antoine Thiery-Vuillemin, Begoña P Valderrama, Anders Ullén, Norihiko Tsuchi...> ;European Urology. 2024 Feb 1
- Join now to see all
Journal Articles
- Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial CarcinomaCora N Sternberg, Jeanny B Aragon-Ching, Daniel P Petrylak, Petros Grivas, The New England Journal of Medicine
- The Emerging Role of Combination Angiogenesis Inhibitors and Immune Checkpoint Inhibitors in the Treatment of Metastatic Renal Cell CancerNizam A, Logan R, Gupta B, Aragon-Ching, JB, Kidney Cancer, 8/7/2019
Lectures
- Metastatic RCC trials: Balancing efficacy and quality-of-lifeEAU Annual Congress 2021 - 7/9/2021
- Current Approaches to Urothelial and Variant Cancers: Tumor Board PresentationASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
- ABCs of ADTHotel Monaco, Washington, DC; National Alliance of State Prostate Cancer Coalition - 10/19/2019
- Join now to see all
Other
- First-Line Treatment of Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: The Pursuit of Improved OutcomesAragon-Ching JB, Grivas P., ASCO Daily News
https://dailynews.ascopubs.org/do/first-line-treatment-cisplatin-ineligible-patients-metastatic-urothelial-carcinoma
1/17/2023 - Advances in Genitourinary Cancers at ASCO22Neeraj Agrawal and Jeanny Aragon-Ching, ASCO Daily News
https://dailynews.ascopubs.org/do/10.1200/ADN.22.0618/full/
6/18/2022 - Podcast: Key Posters on Advances in GU Cancers at ASCO22Neeraj Agrawal and Jeanny Aragon-Ching, ASCO Daily News
https://dailynews.ascopubs.org/do/10.1200/ADN.22.05.26.2/full/
5/26/2022 - Join now to see all
Authored Content
- How We Treat Metastatic Renal Cell Carcinoma: Options Beyond First-Line TherapyJanuary 2023
- Controversies Surrounding the Use of Novel Antiandrogens in Nonmetastatic Castrate-Resistant Prostate CancerNovember 2019
- Perspective on Targeted radiation therapy yields high response rates in metastatic prostate cancerFebruary 2019
- The Evolving Treatment Landscape for Nonmetastatic Castration-Resistant Prostate CancerJanuary 2019
- Contemporary systemic therapy for advanced urothelial carcinoma11/1/2018
- Prostate, Bladder & Non-urothelial cancers, RCC and Germ Tumor Questions9/21/2017
- Join now to see all
Press Mentions
Pembrolizumab Could Help Avert Cystectomy for Patients with BCG-Unresponsive NMIBCFebruary 20th, 2019
ASCO 2018: Challenges of Perioperative Systemic Therapy of Localized Urothelial CancerJune 2nd, 2018
Management of Rare Genitourinary TumorsMay 14th, 2018- Join now to see all
Committees
- Track Chair Urothelial Carcinoma, ASCO GU Cancers Symposium Committee 2019 2018 - Present
- Member, Bladder; Track co-chair, Renal, ASCO GU Cancers Symposium Committee 2017 - 2018
- Member, ASCO Cancer Education Committe 2016 - 2018
- Member, Prostate; Track Chair - Renal, ASCO GU Cancers Committee 2016 - 2017
Professional Memberships
- Fellow
- Member
Hospital Affiliations
Inova Fairfax Medical CampusFalls Church, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
